Increased resting energy expenditure compared with predictive theoretical equations in amyotrophic lateral sclerosis.

Amyotrophic lateral sclerosis Evolution Metabolic rate Predictive equation Resting energy expenditure Survival

Journal

Nutrition (Burbank, Los Angeles County, Calif.)
ISSN: 1873-1244
Titre abrégé: Nutrition
Pays: United States
ID NLM: 8802712

Informations de publication

Date de publication:
09 2020
Historique:
received: 28 07 2019
revised: 12 01 2020
accepted: 01 03 2020
pubmed: 7 5 2020
medline: 24 6 2021
entrez: 7 5 2020
Statut: ppublish

Résumé

Approximately 50% to 60% of amyotrophic lateral sclerosis (ALS) is characterized by an increase in metabolic rate. The Harris and Benedict (HB) 1919 formula is the equation mainly used to calculate resting energy expenditure (cREE) compared with measured REE (mREE) by indirect calorimetry (IC), but other formulas are also applied in current practice. The present study aimed to assess mREE in patients with ALS compared with 12 cREE formulas and study the relevant threshold of REE variation to screen patients with a higher evolving risk. Nutritional assessments and body composition (by bioimpedance analysis) were performed in patients with ALS. mREE was measured by IC, and cREE was calculated using the HB 1919, HB 1984, World Schofield, De Lorenzo, Johnstone, Mifflin, World Health Organization/Food and Agriculture Organization, Owen, Fleisch, Wang, Rosenbaum, and Nelson formulas. Functional and respiratory evolution and survival by log-rank test according to two thresholds of REE variation (10% and 20%) were studied. A total of 315 patients with ALS were included in the study. The median mREE was 1503 kcal/24 h (range, 1290-1698 kcal/24 h), which was higher than all predictive equations (P < 0.0001). Depending on the predictive equation, REE variation >10% and 20% was found in 35.2% to 76.3% and 14.6% to 53.3% of patients with ALS, respectively. Patients with an REE variation >20% with HB 1919 and HB 1984 had a lower survival. Moreover, with this same threshold and the Mifflin formula, patients had higher functional and respiratory evolutions and lower survival. The increase in metabolic rate is present according to the different cREE formulas used compared with IC. In clinical practice, REE formulas (e.g., HB 1919, HB 1984, or Mifflin) can be used as a reference value compared with IC to screen patients with ALS with an REE variation >20% and a higher evolving risk.

Identifiants

pubmed: 32371347
pii: S0899-9007(20)30088-5
doi: 10.1016/j.nut.2020.110805
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

110805

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Pierre Jésus (P)

Nutrition Unit, University Hospital of Limoges, Limoges, France; INSERM (Institut National de la Santé et de la Recherche Médicale), U1094, Tropical Neuroepidemiology, Limoges, France; University of Limoges, UMR_S 1094, Tropical Neuroepidemiology, Institute of Neuroepidemiology and Tropical Neurology, CNRS FR 3503 GEIST, Limoges, France. Electronic address: pierre.jesus@chu-limoges.fr.

Philippe Fayemendy (P)

Nutrition Unit, University Hospital of Limoges, Limoges, France; INSERM (Institut National de la Santé et de la Recherche Médicale), U1094, Tropical Neuroepidemiology, Limoges, France; University of Limoges, UMR_S 1094, Tropical Neuroepidemiology, Institute of Neuroepidemiology and Tropical Neurology, CNRS FR 3503 GEIST, Limoges, France.

Benoit Marin (B)

INSERM (Institut National de la Santé et de la Recherche Médicale), U1094, Tropical Neuroepidemiology, Limoges, France; University of Limoges, UMR_S 1094, Tropical Neuroepidemiology, Institute of Neuroepidemiology and Tropical Neurology, CNRS FR 3503 GEIST, Limoges, France; Center of Epidemiology, Biostatistics and Research Methodology, University Hospital of Limoges, Limoges, France.

Marie Nicol (M)

INSERM (Institut National de la Santé et de la Recherche Médicale), U1094, Tropical Neuroepidemiology, Limoges, France; University of Limoges, UMR_S 1094, Tropical Neuroepidemiology, Institute of Neuroepidemiology and Tropical Neurology, CNRS FR 3503 GEIST, Limoges, France; Amyotrophic lateral sclerosis center, University Hospital of Limoges, Limoges, France.

Huguette Sourisseau (H)

Nutrition Unit, University Hospital of Limoges, Limoges, France.

Yves Boirie (Y)

Université Clermont Auvergne, CHU Clermont-Ferrand, Service de Nutrition Clinique, CRNH Auvergne, Clermont-Ferrand, France; Université Clermont Auvergne, INRA, UNH, Unité de Nutrition Humaine, CRNH Auvergne, Clermont-Ferrand, France.

Stéphane Walrand (S)

Université Clermont Auvergne, INRA, UNH, Unité de Nutrition Humaine, CRNH Auvergne, Clermont-Ferrand, France.

Najate Achamrah (N)

Nutrition Department, Clinical Investigation Centre CIC-1404, University Hospital, Rouen, France; INSERM UMR 1073, Nutrition, Inflammation and Gut-Brain axis dysfunction, Normandie University, UNIROUEN, Rouen, France.

Moïse Coëffier (M)

Nutrition Department, Clinical Investigation Centre CIC-1404, University Hospital, Rouen, France; INSERM UMR 1073, Nutrition, Inflammation and Gut-Brain axis dysfunction, Normandie University, UNIROUEN, Rouen, France.

Pierre-Marie Preux (PM)

INSERM (Institut National de la Santé et de la Recherche Médicale), U1094, Tropical Neuroepidemiology, Limoges, France; University of Limoges, UMR_S 1094, Tropical Neuroepidemiology, Institute of Neuroepidemiology and Tropical Neurology, CNRS FR 3503 GEIST, Limoges, France; Center of Epidemiology, Biostatistics and Research Methodology, University Hospital of Limoges, Limoges, France.

Géraldine Lautrette (G)

Amyotrophic lateral sclerosis center, University Hospital of Limoges, Limoges, France.

Philippe Couratier (P)

INSERM (Institut National de la Santé et de la Recherche Médicale), U1094, Tropical Neuroepidemiology, Limoges, France; University of Limoges, UMR_S 1094, Tropical Neuroepidemiology, Institute of Neuroepidemiology and Tropical Neurology, CNRS FR 3503 GEIST, Limoges, France; Amyotrophic lateral sclerosis center, University Hospital of Limoges, Limoges, France.

Jean-Claude Desport (JC)

Nutrition Unit, University Hospital of Limoges, Limoges, France; INSERM (Institut National de la Santé et de la Recherche Médicale), U1094, Tropical Neuroepidemiology, Limoges, France; University of Limoges, UMR_S 1094, Tropical Neuroepidemiology, Institute of Neuroepidemiology and Tropical Neurology, CNRS FR 3503 GEIST, Limoges, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH